183 related articles for article (PubMed ID: 23007878)
1. Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma.
Aprile G; Avellini C; Reni M; Mazzer M; Foltran L; Rossi D; Cereda S; Iaiza E; Fasola G; Piga A
Tumour Biol; 2013 Feb; 34(1):131-7. PubMed ID: 23007878
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
[TBL] [Abstract][Full Text] [Related]
3. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.
Matsubayashi H; Infante JR; Winter J; Klein AP; Schulick R; Hruban R; Visvanathan K; Goggins M
Cancer Biol Ther; 2007 Oct; 6(10):1569-75. PubMed ID: 18000398
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis.
Perini MV; Montagnini AL; Coudry R; Patzina R; Penteado S; Abdo EE; Diniz A; Jukemura J; da Cunha JE
ANZ J Surg; 2015 Mar; 85(3):174-8. PubMed ID: 24112413
[TBL] [Abstract][Full Text] [Related]
5. COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.
Pomianowska E; Schjølberg AR; Clausen OP; Gladhaug IP
BMC Cancer; 2014 Jun; 14():458. PubMed ID: 24950702
[TBL] [Abstract][Full Text] [Related]
6. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.
Weber CK; Sommer G; Michl P; Fensterer H; Weimer M; Gansauge F; Leder G; Adler G; Gress TM
Gastroenterology; 2001 Sep; 121(3):657-67. PubMed ID: 11522750
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
8. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
Shyr YM; Su CH; Li AF; Wu CW; Lui WY
Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
[TBL] [Abstract][Full Text] [Related]
9. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
11. The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma.
Hollander LL; Guo X; Salem RR; Cha CH
J Surg Res; 2015 Aug; 197(2):219-24. PubMed ID: 25982376
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma.
Collins AL; Rock J; Malhotra L; Frankel WL; Bloomston M
Ann Surg Oncol; 2012 Aug; 19(8):2673-8. PubMed ID: 22461132
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
[TBL] [Abstract][Full Text] [Related]
14. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.
Zhang Y; Xu J; Hua J; Liu J; Liang C; Meng Q; Wei M; Zhang B; Yu X; Shi S
J Immunother Cancer; 2019 Aug; 7(1):233. PubMed ID: 31464648
[TBL] [Abstract][Full Text] [Related]
15. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
16. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
[TBL] [Abstract][Full Text] [Related]
17. High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma.
Smith R; Xue A; Gill A; Scarlett C; Saxby A; Clarkson A; Hugh T
World J Surg; 2007 Mar; 31(3):493-502; discussion 503. PubMed ID: 17219285
[TBL] [Abstract][Full Text] [Related]
18. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.
Chadha KS; Khoury T; Yu J; Black JD; Gibbs JF; Kuvshinoff BW; Tan D; Brattain MG; Javle MM
Ann Surg Oncol; 2006 Jul; 13(7):933-9. PubMed ID: 16788754
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial transcription factor a worsens the clinical course of patients with pancreatic cancer through inhibition of apoptosis of cancer cells.
Yamauchi M; Nakayama Y; Minagawa N; Torigoe T; Shibao K; Yamaguchi K
Pancreas; 2014 Apr; 43(3):405-10. PubMed ID: 24622070
[TBL] [Abstract][Full Text] [Related]
20. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma.
Lu CD; Morita S; Ishibashi T; Hara H; Isozaki H; Tanigawa N
Cancer; 1999 Mar; 85(6):1250-60. PubMed ID: 10189129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
